Characterisation of PGE2 receptors mediating increased vascular permeability in inflammation.
Armstrong
R A
RA
Department of Pharmacology, University of Edinburgh, U.K.
Matthews
J S
JS
Jones
R L
RL
Wilson
N H
NH
D000527:Alprostadil / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D002199:Capillary Permeability / Q000187:drug effects; D015232:Dinoprostone / Q000031:analogs & derivatives / Q000494:pharmacology*; D004357:Drug Synergism; D007249:Inflammation / Q000503:physiopathology; D011817:Rabbits; D011982:Receptors, Prostaglandin / Q000145:classification / Q000187:drug effects / Q000502:physiology*; D018078:Receptors, Prostaglandin E; D012867:Skin / Q000098:blood supply / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D011982:Receptors, Prostaglandin; D018078:Receptors, Prostaglandin E; C067521:11-deoxyprostaglandin E2-1-alcohol; C016767:sulprostone; C032405:11-deoxy-16-phenoxy-17,18,19,20-tetranorprostaglandin E1; D000527:Alprostadil; C048491:butaprost; D015232:Dinoprostone; D001920:Bradykinin; C034008:11-deoxyprostaglandin E1